Severe Combined Immunodeficiency (SCID) Screening in Arizona: Lessons Learned from the First 2 Years
- 22 June 2022
- journal article
- research article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 42 (6) , 1321-1329
Abstract
Purpose The incidence of severe combined immunodeficiency (SCID) in the USA was reported as 1 in 58,000 live births. In Arizona, it was anticipated that newborn screening would identify two to four cases of SCID per year. This estimate did not consider ethnic nuances in Arizona, with higher percentages of Native American and Hispanic populations compared to national percentages. The true incidence of SCID and non-SCID T cell lymphopenia has not previously been reported in Arizona. Methods A retrospective chart review was performed on all abnormal SCID newborn screening (NBS) tests in Arizona from January 1, 2018, to December 31, 2019, using data from the Arizona Department of Health Services and the Phoenix Children’s Hospital’s electronic medical record [IRB# 20–025]. Results Seven infants were diagnosed with SCID, yielding an incidence of 1 in 22,819 live births. Four of these infants had Artemis-type SCID. Thirteen infants were identified with an abnormal initial NBS which ultimately did not lead to a diagnosis of SCID. Four of these infants were diagnosed with congenital syndromes associated with T cell lymphopenia. Infants of Hispanic ethnicity were over-represented in this cohort. Conclusion Over 2 years, NBS in Arizona confirmed an incidence more than 2.5 times that reported nationally. This increased incidence is likely reflective of Arizona’s unique population profile, with a higher percentage of Native American population. The findings in our non-SCID cohort are in alignment with previously published data, except for an increased percentage of infants of Hispanic/Latino ethnicity, possibly reflecting Arizona’s increased percentage of Hispanic/Latino population compared to the general US population.Keywords
All Related Versions
This publication has 18 references indexed in Scilit:
- Profound T-cell lymphopenia associated with prenatal exposure to purine antagonists detected by TREC newborn screeningThe Journal of Allergy and Clinical Immunology: In Practice, 2017
- Successful newborn screening for SCID in the Navajo NationClinical Immunology, 2015
- Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United StatesJAMA, 2014
- Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009New England Journal of Medicine, 2014
- Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: Results of the first 2 yearsJournal of Allergy and Clinical Immunology, 2013
- Newborn Screening for SCID Identifies Patients with Ataxia TelangiectasiaJournal of Clinical Immunology, 2012
- Early vs. delayed diagnosis of severe combined immunodeficiency: A family perspective surveyClinical Immunology, 2011
- Consanguinity, human evolution, and complex diseasesProceedings of the National Academy of Sciences, 2010
- Lymphocyte subsets in healthy children from birth through 18 years of ageJournal of Allergy and Clinical Immunology, 2003
- A Founder Mutation in Artemis, an SNM1-Like Protein, Causes SCID in Athabascan-Speaking Native AmericansThe Journal of Immunology, 2002